Due to the endocrine profile from these patients clearly showing endocrinopathies associated with brain and eye abnormalities characteristic of SOD, we reasoned that mutations in novel genes or known hypopituitarism or SOD causative genes, other than the reported BRAF variants, could be responsible for the observed clinical phenotype. The gene discussed is SOD1; the disease is endocrine system disorder.